Who owns Fennec Pharmaceuticals Inc?

Top Holders and Investors of Fennec Pharmaceuticals Inc Stock

Find out who owns Fennec Pharmaceuticals Inc, who bought Fennec Pharmaceuticals Inc this quarter, and who sold Fennec Pharmaceuticals Inc?

Fund or Company Name Number of Shares Valued At As Of
Southpoint Capital Advisors 4.00M $25.94M Dec 2019
venBio Select Advisor 1.11M $7.17M Dec 2019
Solas Capital Management 971795 $6.31M Dec 2019
683 Capital Management 950000 $6.17M Dec 2019
Kam Lawrence 834689 $5.42M Dec 2019
Sonic Fund II 834689 $5.42M Dec 2019
Eventide Asset Management 720000 $4.67M Dec 2019
Granahan Investment Management Inc/ma 385880 $2.50M Dec 2019
Oxford Asset Management 59746 $387154 Dec 2019
Susquehanna International 56776 $367908 Dec 2019
Hartford Financial Management 35000 $227150 Dec 2019
BlackRock 34610 $220811 Dec 2019
Weiss Multi-strategy Advisers 26500 $171985 Dec 2019
Wedbush Morgan Securities 24700 $160056 Dec 2019
Renaissance Technologies 23800 $153986 Dec 2019
Sunrise Partners Limited Partnership 22026 $142948 Dec 2019
Goldman Sachs 14224 $92029 Dec 2019
Opaleye Management 12000 $78000 Dec 2019
Meeder Asset Management 6754 $41672 Dec 2019
Wealth Quarterback 6380 $999 Dec 2019
Victory Capital Management 6338 $41006 Dec 2019
Deutsche Bank Aktiengesellschaft 1393 $8998 Dec 2019
Tower Research Capital 1163 $7094 Dec 2019
UBS Group AG 983 $5996 Dec 2019
Morgan Stanley 400 $3000 Dec 2019
Toronto-Dominion Bank 342 $2281 Dec 2019
Springbok Capital Management 244 $2000 Dec 2019
Royal Bank of Canada 77 $0 Dec 2019
Bnp Paribas Arbitrage, Snc 62 $402 Dec 2019
Bank Of Montreal /can/ 18 $0 Dec 2019

Who sold Fennec Pharmaceuticals Inc?

Fund Name Date Sold Shares Held Valued At
Citi Sep 2019 1308 $6003
Jpmorgan Chase & Co Sep 2019 110 $999
Simplex Trading Sep 2019 100 $0

Funds that own Fennec Pharmaceuticals Inc also own: